glp-1 drugs and parkinson's disease Are diabetes like Ozempic coming for disease? — Parkinson Secrets Researching GLP-1 drugs and Parkinson's
Description
Footnotes CONFLICTS OF INTEREST In the last 5 years Adie Viljoen has received lecture honoraria and/or travel support and/or conducts clinical trials funded by: Amarin, Amgen, Astra Zeneca, Boehringer Ingleheim, Daiichi-Sankyo, Lilly, Menarini, NewAmsterdam, Novartis, Novo Nordisk, Pfizer, Regeneron, Sanofi, Takeda, and Tosoh
Cell Physiol Biochem
None of these differences reached statistical significance, though the studies were not powered specifically for this outcome
Medication reduces the burden on your body, but diet and exercise do the heavy lifting
